LFG
TYRA icon

Larson Financial Group’s Tyra Biosciences TYRA Stock Holding History

Larson Financial Group’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79K Sell
150
-145
-49% -$4.8K ﹤0.01% 2793
2026
Q1 		$11.3K Buy
295
+149
+102% +$4.82K ﹤0.01% 2168
2025
Q4 		$3.84K Buy
146
+8
+6% +$147 ﹤0.01% 2562
2025
Q3 		$1.93K Buy
138
+102
+283% +$1.16K ﹤0.01% 2724
2025
Q2 		$345 Buy
+36
New +$342 ﹤0.01% 2950

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Larson Financial Group's TYRA Position: Q2 2026 in Review

Larson Financial Group reduced its Tyra Biosciences (TYRA) stake by 49% in Q2 2026, selling an estimated $4.8K and leaving 150 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2793.

Larson Financial Group first reported a position in TYRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $11.3K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Larson Financial Group held 150 shares of Tyra Biosciences worth $4.79K as of Q2 2026.
  • Larson Financial Group sold 145 Tyra Biosciences shares in Q2 2026, an estimated $4.8K.
  • Tyra Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2793 holding.
  • Larson Financial Group first reported a position in Tyra Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Tyra Biosciences position peaked at $11.3K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.